Many studies have shown that the overexpression of DCLK1 in cancer cells results in induction of EMT, stemness and increased cell migration and invasion, which can be reversed with small molecules targeting the kinase domain of DCLK1 [31,34,35,46,47,126]. Here, DCLK1 is linked to cancer.